Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Cresanto Global Ltd (531207)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531207 NSE: Packaging | Small Cap | Cresanto Global Share Price
₹5.37 0.00 (0.00%)
As on 21-Sep'26 16:59
Cresanto Global Ltd (531207)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531207 NSE: Packaging | Small Cap | Cresanto Global Share Price
₹5.37 0.00 (0.00%)
As on 21-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹2 Cr.
Current Price
₹5.4
52-Week Low / High
₹4 / 5
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
22.5
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
32.27%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹4.3 Cr.
Face Value
₹10
All Time Low / High
₹0.92 / 46.90
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Cresanto Global Ltd a good quality company?
Cresanto Global Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Cresanto Global Ltd performance compare with that of its Peers?
Revenue growth of Cresanto Global Ltd vs industry peers?
Cresanto Global Ltd revenue CAGR is %, compared to the industry median CAGR of 0.00%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Cresanto Global Ltd?
Promoters hold 32.27% of the Cresanto Global Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Cresanto Global Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 5.7% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Cresanto Global Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -26.4% | -41.3% | -58.4% | -105.5% | -94.4% | 0% | 0% | 0% | 0% | 0% | - |
| Value Creation Index ⓘ | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 |
| Sales YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - |
| Adj EPS ⓘ | -0.1 | -0.1 | -0.1 | -0.1 | -0.2 | -0.2 | -0.4 | -0.2 | -1.3 | -1 | -0.9 |
| YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - |
| BVPS (₹) ⓘ | -4.3 | -4.4 | -4.5 | -4.6 | -4.8 | -5 | -5.4 | -5.6 | -6.1 | -7.1 | -7.2 |
| Adj Net Profit ⓘ | -0 | -0 | -0 | -0.1 | -0.1 | -0.1 | -0.2 | -0.1 | -0.5 | -0.4 | -0 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 0 | -0 | 0 | -2.2 | -0.2 | -0.1 | -0.5 | -0.3 | - |
| Debt/CF from Ops. ⓘ | 24433.3 | 7705.3 | 1737.8 | -7238.4 | 7046.6 | 0 | 0 | -40.1 | -5 | -10.4 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | NA | ||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||
| BVPSⓘ | NA | NA | NA | NA | ||||
| Share Price | 5.7% | 39.1% | 31.7% | 47.1% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 1.9 | 2 | 1.7 | 2.9 | 3.4 | 3.9 | 7.7 | 4.3 | 21.5 | 15.4 | 13 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -544.2 | -14.8 |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -798.3 | -794.2 |
| Debt to Equity ⓘ | -1.1 | -1.1 | -1 | -1 | -1.1 | 0 | 0 | -1 | -0.9 | -0.9 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117 | 43 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -91 |
Valuation of Cresanto Global - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Cresanto Global Ltd FAQs
The current trading price of Cresanto Global on 21-Sep-2026 16:59 is ₹5.37.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Sep-2026 the market cap of Cresanto Global stood at ₹2.29 Cr
The latest P/E ratio of Cresanto Global as of 20-Sep-2026 is 0.00.
The latest P/B ratio of Cresanto Global as of 20-Sep-2026 is -0.75.
The 52-week high of Cresanto Global is ₹5.37 and the 52-week low is ₹3.83.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Cresanto Global is ₹0.05 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Cresanto Global Ltd is a below average quality company.
The key valuation ratios of Cresanto Global Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Cresanto Global Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Cresanto Global Ltd
Raymed Labs was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities. the company is located at Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymed’s quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area.
Raymed strives on a well organized management team of skilled and highly trained professionals from different streams. This team contains chemists, pharmacists, marketing professionals with in-depth knowledge & requirements for human and animal products.
Products range:
- RAMPICILLIN - Ampicillin, a semisynthetic penicillin
- RAMPICLOX - Equal quantities of Ampicillin and Cloxacillin
- RAMPIMOX - Equal quantities of Amoxycillin and Cloxacillin
- RAMYKACIN - Amikacin Sulphate
- OXYTETRACYCLINE - The most common Antibiotic in Veterinary Practice
- RAMYFENAC-Diclofenac Sodium. It is a potent non steroidal Anti-inflammatory, Analgesic & Antipyretic for human use
- RAMAMINE- Chlorpheniramine Maleate. The most potent & effective Anti-histaminic for veterinary use
- RAMYDEX-Dexamethasone Sodium Phosphate. Anti-inflammatory, Anti-allergic, Gluco-corticoid adjuvant with Antibiotic therapy
- RAMYCIN-Gentamycin Sulphate
- RAMYPINE - Atropin Sulphate. The drug has anticholenergic effect in veterinary use.
- RAMYCHLOR - Chloramphenicol
- REALOPAR - Paracetamol
- RAYVIL - Pheniramine Maleate
- RAMALGIN-P - Phenylbutazone and Analgin with Lignocaine: A unique combination of highly effective analgesic, antispasmodic, anti-inflammatory & Antipyretic for veterinary use.
- RAMYSCAB - Sulphur with Benzyl Benzoate in Lidocaine base: An ideal treatment of Scabies & other dermal problems in animals
- RAMYVIT PLEX - Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B12 with Liver Extract: crude injection and ideal treatment of Scabies & other dermal problems in animals
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
